Healthcare provider profile · identity verified

Edward Stephen Walker, M.D.

Internal Medicine · FORT LAUDERDALE, FL · NPI 1619073574

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	598	90
Atorvastatin Calcium	Atorvastatin Calcium	525	105
Eliquis	Apixaban	264	52
Pantoprazole Sodium	Pantoprazole Sodium	259	61
Amlodipine Besylate	Amlodipine Besylate	252	62
Losartan Potassium	Losartan Potassium	210	46
Escitalopram Oxalate	Escitalopram Oxalate	208	38
Donepezil Hcl	Donepezil Hcl	183	31
Metoprolol Succinate	Metoprolol Succinate	175	38
Furosemide	Furosemide	174	40
Potassium Chloride	Potassium Chloride	169	33
Trazodone Hcl	Trazodone Hcl	169	40
Metoprolol Tartrate	Metoprolol Tartrate	162	34
Quetiapine Fumarate	Quetiapine Fumarate	159	39
Lisinopril	Lisinopril	152	31
Omeprazole	Omeprazole	139	25
Tamsulosin Hcl	Tamsulosin Hcl	136	29
Memantine Hcl	Memantine Hcl	129	19
Mirtazapine	Mirtazapine	127	23
Simvastatin	Simvastatin	125	28
Xarelto	Rivaroxaban	122	14
Gabapentin	Gabapentin	119	27
Levetiracetam	Levetiracetam	115	15
Famotidine	Famotidine	108	21
Metformin Hcl	Metformin Hcl	106	22
Rosuvastatin Calcium	Rosuvastatin Calcium	99	25
Clopidogrel	Clopidogrel Bisulfate	89	26
Latanoprost	Latanoprost	88	19
Finasteride	Finasteride	85	13
Valsartan	Valsartan	80	18
Allopurinol	Allopurinol	73	15
Atenolol	Atenolol	72	17
Ezetimibe	Ezetimibe	70	13
Sertraline Hcl	Sertraline Hcl	70	17
Carvedilol	Carvedilol	65	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	65	25
Citalopram Hbr	Citalopram Hydrobromide	57	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	54	suppressed
Glipizide	Glipizide	49	suppressed
Buspirone Hcl	Buspirone Hcl	44	suppressed
Azithromycin	Azithromycin	43	39
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Synthroid	Levothyroxine Sodium	41	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	40	suppressed
Cephalexin	Cephalexin	40	31
Midodrine Hcl	Midodrine Hcl	39	suppressed
Prednisone	Prednisone	37	13
Bumetanide	Bumetanide	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	13
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Amiodarone Hcl	Amiodarone Hcl	33	12
Spironolactone	Spironolactone	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	31	suppressed
Divalproex Sodium	Divalproex Sodium	30	suppressed
Lamotrigine	Lamotrigine	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Seroquel	Quetiapine Fumarate	28	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	25	suppressed
Folic Acid	Folic Acid	24	suppressed
Alprazolam	Alprazolam	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Bupropion Hcl	Bupropion Hcl	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Megestrol Acetate	Megestrol Acetate	21	suppressed
Methenamine Hippurate	Methenamine Hippurate	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Mupirocin	Mupirocin	20	15
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	18	11
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Colestipol Hcl	Colestipol Hcl	16	suppressed
Methylprednisolone	Methylprednisolone	16	12
Novolog Flexpen	Insulin Aspart	16	suppressed
Sotalol Af	Sotalol Hcl	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Bicalutamide	Bicalutamide	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	11
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Anastrozole	Anastrozole	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error